Market Tracker

07/22 6:45pm ET

Trovagene Inc (NASDAQ:TROV)

5.04
Delayed Data
As of Jul 22
 -0.04 / -0.79%
Today’s Change
2.85
Today|||52-Week Range
10.08
-6.67%
Year-to-Date

Today’s Trading

Previous close5.08
Today’s open5.06
Day’s range5.02 - 5.27
Volume363,312
Average volume (3 months)436,878
Market cap$150.5M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-21.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.03+0.60%
LNTHLantheus Holdings In...+0.08+1.90%
QTNTQuotient Ltd+0.36+5.16%
OXFDOxford Immunotec Glo...-0.13-1.55%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts